{{Rsnum
|rsid=35141484
|Gene=KLHL5
|Chromosome=4
|position=39086721
|Orientation=plus
|GMAF=0.02755
|Gene_s=KLHL5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 98.2 | 1.8 | 0.0
| YRI | 84.1 | 15.2 | 0.7
| ASW | 82.5 | 17.5 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 69.4 | 25.9 | 4.6
| MEX | 0.0 | 0.0 | 0.0
| MKK | 75.2 | 23.5 | 1.3
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23829686
  |Trait=Asthma (childhood onset)
  |Title=Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.
  |RiskAllele=
  |Pval=3E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}